Aarti Drugs announces 41st AGM on Sep 26, 2026, to be held via VC/OAVM
Aarti Drugs Limited will hold its 41st Annual General Meeting on September 26, 2026. The meeting will be conducted via Video Conferencing/Other Audio Visual Means. The Annual Report for FY 2025-26 and the AGM notice have been shared with shareholders.
This is a standard procedural announcement about the AGM, which is a regular corporate event. It does not involve any new strategic decisions, financial performance changes, or operational developments that would significantly impact the company's stock or business operations.
The announcement is a routine corporate communication regarding the scheduling of the Annual General Meeting and the dissemination of the Annual Report. It does not contain any new financial results or significant business updates that would sway sentiment.
Aarti Drugs Limited has announced the schedule for its 41st Annual General Meeting (AGM). The meeting is slated to be held on Saturday, September 26, 2026, at 11:00 a.m. (IST). In compliance with current regulations and circulars from the Ministry of Corporate Affairs (MCA) and SEBI, the AGM will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The company has dispatched the Annual Report for the Financial Year 2025-26 and the Notice of the AGM electronically to shareholders whose email addresses are registered. For shareholders whose email addresses are not registered, letters containing a weblink to the Annual Report have been sent. The Annual Report and AGM Notice are also available on the company's website at https://www.aartidrugs.com/reports-fillings-annual-reports.
A plain-language summary of a public exchange filing by Aarti Drugs Limited. Read the original for the full detail.